Exodus Point Capital Management, LP Cullinan Oncology, Inc. Transaction History

Exodus Point Capital Management, LP

  • $16.4 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
SELL
$10.17 - $19.02 $197,420 - $369,216
-19,412 Reduced 54.29%
16,347 $279,000
Q3 2023

Nov 09, 2023
SELL
$9.05 - $11.72 $30,788 - $39,871
-3,402 Reduced 8.69%
35,759 $324,000
Q2 2023

Aug 10, 2023
SELL
$8.8 - $13.4 $43,920 - $66,879
-4,991 Reduced 11.3%
39,161 $421,000
Q1 2023

May 11, 2023
BUY
$10.2 - $11.91 $450,350 - $525,850
44,152 New
44,152 $452,000

Others Institutions Holding CGEM

# of Institutions
146
Shares Held
67.6M
Call Options Held
612K
Put Options Held
118K
View Full List

About Cullinan Oncology, Inc.

CGEM Quotes by TradingView
  • Ticker CGEM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,612,200
  • Market Cap $499M
  • Description
  • Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...
More about CGEM
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email